1 terminated, 1 withdrawn. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Maprotiline: new trials by email Literature Review of Maprotiline trials Research Report on Maprotiline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma Temozolomide, Tamoxifen, Maprotiline - Glioblastoma, Brain Tumor | Phase 1 | Withdrawn | University of Rochester | 2022-06-01 | 2022-08-22 | |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
Anxiety Disorders (1) · Brain Neoplasms (1) · Dementia (1) · Depression (1) · Glioblastoma (1) · Psychophysiologic Disorders (1) · Schizophrenia (1)
Hannover Medical School (1) · University of Rochester (1)
Germany (1)
Helge Frieling, Prof., MD (1) · Nimish Mohile, MD (1)